MedPath

The effect of vaginal ointment Myrtus on Candida Vaginitis

Phase 2
Conditions
candidiasis vaginitis.
Acute vaginitis
Registration Number
IRCT138810111744N4
Lead Sponsor
Vice chancellor for research, Lorestan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
60
Inclusion Criteria

18-50 years women with positive culture of vaginal discharge due to candidiasis

Exclusion Criteria

Age less than 18 and more than 50 years old; pregnancy; diabetes; corticosteroid therapy and antibiotic therapy in two weeks ago.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The assay of effective dosage of vaginal ointment of Myrtus on treatment of candidiasis vaginitis. Timepoint: Before and a week after of tial. Method of measurement: Questioner, examination and culture of vaginal discharge.
Secondary Outcome Measures
NameTimeMethod
Failure of treatment. Timepoint: A week after trial. Method of measurement: Questioner, examination and culture of vaginal discharge.
© Copyright 2025. All Rights Reserved by MedPath